
Topic
Immunotherapy
59 Podcasts • 29 Cases • 8 Courses on BackTable
Hear how experienced physicians approach Immunotherapy on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Episode # 82 • 22 Sept 2026
Advances in Perioperative Colorectal Cancer Management
How much of perioperative colorectal cancer management has changed in just one year, and what does it mean for patient care? On this episode of BackTable Tumor Board, Dr. Jun Gong is joined by Dr. Ibrahim Sahin and Dr. Alexandra Gangi to review the latest practice-changing data in colon and rectal cancer. They discuss observation versus maintenance immunotherapy in MSI-high disease, the CHALLENGE trial's surprising results on exercise and disease-free survival, and the evolving role of ctDNA and local therapies after liver metastasis resection.
More on Immunotherapy
Loading recent podcasts…
Tumor Board # 82
Sep 21, 2026
with Dr. Alexandra Gangi, Dr. Ibrahim Sahin, Dr. Jun Gong
How much of perioperative colorectal cancer management has changed in just one year, and what does it mean for patient...
Tumor Board # 75
Aug 3, 2026
with Dr. Cathy Eng, Dr. Jun Gong
Is it time to rethink the definition of “cure” for stage IV colorectal cancer? In this episode of BackTable Tumor...
1,800+ listens
Industry # 103
Jun 29, 2026
with Dr. Basil Kahwash, Anish Parikh
How do you protect your time, stay current, and thrive after leaving academic medicine for private practice in a...
Vascular & IR # 655
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone, Dr. Zach Berman
How is Y90 radioembolization rewriting the rules for managing large HCC tumors and creating new curative-intent...
1,800+ listens
ENT & Allergy # 290
Aug 31, 2026
with Dr. Kara Wada, Dr. Basil Kahwash
With no FDA-approved therapies for Sjögren’s disease, how can ENTs and allergists provide effective care and keep up...
1,100+ listens
Tumor Board # 74
Jul 27, 2026
with Dr. Chih-Yi Liao, Dr. Robert Ramirez, Dr. Lingling Du
What first-line therapies should be considered for patients with higher-grade, metastatic neuroendocrine tumors (NETs)?...
ENT & Allergy # 279
Jun 22, 2026
with Dr. Karen Kaufman, Dr. Ashley Agan
When should recurrent sinus infections trigger an allergy or immune workup? In this episode of the BackTable ENT &...
1,200+ listens
Urology # 305
Jun 1, 2026
with Dr. Sam Chang, Dr. Ruchika Talwar
Ready to move beyond “one-size-fits-all” for BCG-unresponsive NMIBC? In this episode of BackTable Urology, Dr. Ruchika...
1,500+ listens
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
Tumor Board Case
Jun 16, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
Tumor Board Case
Jun 16, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Urology Course
3 hours, 28 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.







